Skip to content

Airway assessment by optical coherence tomography

Exploratory clinical trial using optical coherence tomography for subglottic stenosis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052240200
Enrollment
8
Registered
2024-11-28
Start date
2024-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subglottic stenosis Laryngostenosis

Interventions

OFDI system: The OFDI intravascular imaging system "LUNAWAVE" and imaging catheter "FastView" (Terumo Corporation) are used. The purpose of this product is to image and examine the vessel lumen and ve
Tomography, Optical Coherence

Sponsors

Bitoh Yuko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following selection criteria and none of the following exclusion criteria will be eligible for inclusion in this clinical study 1. those undergoing rigid bronchoscopy for subglottic stenosis (Myer-Cotton classification Grade I-III) due to clinical necessity. 2. those undergoing airway management with a tracheostomy tube after tracheostomy 3. who are at least 3 years of age at the time of obtaining consent. 4. who understand the content of the examination and the purpose of the research and are able to obtain written consent from themselves or a substitute.

Exclusion criteria

Exclusion criteria: 1. who have a complete obstruction of subglottic space (Myer-Cotton classification Grade IV) or a severe stenotic lesion that is expected to be difficult to pass an OFDI catheter. 2. who are or may be pregnant or breast-feeding. 3. other subjects who are deemed inappropriate as subjects by the principal investigator or a sub-investigator of the study.

Design outcomes

Primary

MeasureTime frame
Technical success of imaging of subglottic stenosis by OCT. 3/4 circumference of the stenosis is considered technical success when 3/4 circumference of the stenosis can be imaged by OCT.

Secondary

MeasureTime frame
(Efficacy endpoints) Images obtained by rigid bronchoscopy or CT Examination time (Safety endpoints) No adverse events due to OCT imaging or catheterization Catheter failure No occurrence of disease

Contacts

Public ContactYuki Komyo

Kobe University Hospital

vb1ue28@med.kobe-u.ac.jp+81-78-382-5943

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026